Skip to main content
. 2017 Nov 20;12(11):e0187804. doi: 10.1371/journal.pone.0187804

Table 1. The comparison of demographic data among the control and patients with CHF.

Control
(n = 20)
NYHA I/II
(n = 32)
NYHA III
(n = 42)
NYHA IV
(n = 30)
Men, n (%) 12 (60.00) 32 (61.54) 30 (57.69) 27 (67.50)
Age (y) 71.50±8.58 71.33±9.10 69.81±8.06 70.02±6.31
BMI, kg/m2 22.25±3.11 21.15±2.93 21.92±2.73 22.52±3.20
CHF causes, n (%)
    Hypertensive heart diseases - 15 17 16
    Ischemic heart diseases - 10 13 13
    Dilated cardiomyopathy - 3 7 6
    Valvular diseases - 2 4 3
    Others - 2 1 2
SBP (mmHg) 128.75±2.35 129.00±2.41 127.83±5.33 127.71±2.78
DBP (mmHg) 78.45±3.76 79.13±3.31 77.52±3.43 80.59±2.41
Heart rate (bpm) 79.28±8.35 82.63±7.62 88.59±7.10 84.13±2.69
Diabetes, n (%) 0 6 8 6
Smoking, n (%) 0 9 13 8
Alcohol, n (%) 0 6 10 5
Symptoms
    Abdominal pain 0 0 2 2
    Weight loss 0 3 4 3
    Bloating 0 2 5 3
    Diarrhea 0 0 0 0
Ejection fraction (%) 64.17±7.61 47.11±11.45a 43.47±14.15a,b 39.99±11.60a,b,c
NT-proBNP (pg/ml) 36.27±8.93 1174.87±297.36a 1315.53±309.54a,b 1400.20±557.21a,b,c
Total protein (g/L) 63.57±6.26 63.39±7.71 61.53±7.12a,b 58.92±8.33a,b,c
Albumin (g/L) 49.82±5.11 42.15±4.37a 36.38±7.55a,b 31.53±6.73a,b,c
Pro-albumin (mg/L) 326.20±27.12 195.73±42.56a 142.97±51.29a,b 122.36±36.75a,b,c
Hemoglobin (g/L) 135.71±12.28 123.57±12.67 110.92±14.32 112.36±16.95
sCr (μmol/L) 44.84±11.96 53.26±13.67 58.14±15.49a 87.55±18.76a,b,c
BUN (mmol/L) 3.98±0.93 4.77±1.32 6.92±2.06a,b 8.15±2.68a,b,c
TNF-α (pg/mL) 96.67±17.48 121.85±36.30 204.08±68.81a,b 282.07±71.80a,b,c
IL-1β (pg/mL) 20.84±14.39 37.48±15.97a 47.64±21.73a,b 76.72±21.78a,b,c
IL-6 (pg/mL) 4.54±3.18 8.87±3.40a 10.87±4.52a 13.32±5.93a,b,c
Leptin (ng/mL) 10.97±2.35 9.61±2.75 7.09±2.46a,b 5.33±2.90a,b,c

CHF: chronic heart failure; NYHA:New York Heart Association; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; NT-proBNP: N-terminal pro-B type natriuretic peptide; sCr: serum creatinine; BUN: blood urea nitrogen; TNF-α: tumor necrosis factor-α; IL-1β: interleukin-1β; IL-6: interleukin-6. Values expressed in mean±SD or frequency

aP<0.05: versus control

bP<0.05: versus NYHA I/II

cP<0.05: versus NYHA III.